| 0 |
ANTITHROMBIN III |
1 |
0.0625 |
| 1 |
WALLED-OFF PANCREATIC NECROSIS |
1 |
0.0556 |
| 2 |
RECTOVAGINAL SEPTUM ABSCESS |
1 |
0.0455 |
| 3 |
KNUCKLE PADS |
1 |
0.0435 |
| 4 |
DRUG METABOLITE LEVEL HIGH |
3 |
0.0357 |
| 5 |
ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA |
1 |
0.0294 |
| 6 |
CENTRAL HYPOTHYROIDISM |
9 |
0.0272 |
| 7 |
MULTIPLE LENTIGINES SYNDROME |
1 |
0.0263 |
| 8 |
PERINEAL NECROSIS |
1 |
0.0244 |
| 9 |
GASTROINTESTINAL DILATION PROCEDURE |
1 |
0.0213 |
| 10 |
PROSTATITIS ESCHERICHIA COLI |
1 |
0.0200 |
| 11 |
JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA |
1 |
0.0196 |
| 12 |
VIRAL TONSILLITIS |
1 |
0.0179 |
| 13 |
COAGULATION FACTOR VII LEVEL DECREASED |
2 |
0.0179 |
| 14 |
GENETIC POLYMORPHISM |
1 |
0.0175 |
| 15 |
MYELODYSPLASTIC SYNDROME TRANSFORMATION |
9 |
0.0173 |
| 16 |
HEPATIC CANDIDIASIS |
1 |
0.0147 |
| 17 |
HISTIOCYTIC SARCOMA |
1 |
0.0128 |
| 18 |
GASTROENTERITIS ASTROVIRAL |
1 |
0.0125 |
| 19 |
BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA |
1 |
0.0123 |
| 20 |
PORTAL SHUNT |
1 |
0.0123 |
| 21 |
ADRENOCORTICAL CARCINOMA |
1 |
0.0114 |
| 22 |
ANTITHROMBIN III DEFICIENCY |
1 |
0.0112 |
| 23 |
MUCOCUTANEOUS CANDIDIASIS |
1 |
0.0108 |
| 24 |
PULMONARY HISTOPLASMOSIS |
1 |
0.0100 |
| 25 |
OVERGROWTH FUNGAL |
1 |
0.0097 |
| 26 |
ACQUIRED FACTOR V DEFICIENCY |
1 |
0.0091 |
| 27 |
BILIRUBIN CONJUGATED ABNORMAL |
1 |
0.0090 |
| 28 |
FISTULA INFLAMMATION |
1 |
0.0081 |
| 29 |
VIRAL SKIN INFECTION |
1 |
0.0081 |
| 30 |
FEBRILE BONE MARROW APLASIA |
32 |
0.0075 |
| 31 |
RELAPSING FEVER |
2 |
0.0069 |
| 32 |
PLACENTAL TRANSFUSION SYNDROME |
1 |
0.0069 |
| 33 |
GALLBLADDER OEDEMA |
2 |
0.0068 |
| 34 |
ALLERGIC TRANSFUSION REACTION |
1 |
0.0066 |
| 35 |
MYCOPLASMA TEST POSITIVE |
1 |
0.0066 |
| 36 |
SECONDARY HYPOTHYROIDISM |
1 |
0.0065 |
| 37 |
GASTROENTERITIS ROTAVIRUS |
2 |
0.0065 |
| 38 |
COAGULATION FACTOR V LEVEL DECREASED |
2 |
0.0061 |
| 39 |
LENTIGO |
3 |
0.0060 |
| 40 |
ENTEROVIRUS TEST POSITIVE |
1 |
0.0057 |
| 41 |
HERPES ZOSTER MENINGOENCEPHALITIS |
2 |
0.0056 |
| 42 |
INFLUENZA B VIRUS TEST POSITIVE |
1 |
0.0055 |
| 43 |
ACUTE MONOCYTIC LEUKAEMIA |
1 |
0.0055 |
| 44 |
CUTANEOUS MUCORMYCOSIS |
1 |
0.0054 |
| 45 |
HIGH-GRADE B-CELL LYMPHOMA |
1 |
0.0053 |
| 46 |
PERINEAL INFECTION |
1 |
0.0051 |
| 47 |
NEUTROPHIL COUNT |
1 |
0.0048 |
| 48 |
CHOLESTASIS OF PREGNANCY |
2 |
0.0043 |
| 49 |
NECROTISING SOFT TISSUE INFECTION |
1 |
0.0043 |
| 50 |
MUCOSAL INFECTION |
1 |
0.0043 |
| 51 |
SWEAT GLAND TUMOUR |
1 |
0.0043 |
| 52 |
SPONTANEOUS BACTERIAL PERITONITIS |
1 |
0.0041 |
| 53 |
EPSTEIN BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER |
2 |
0.0041 |
| 54 |
CUTANEOUS LEISHMANIASIS |
1 |
0.0040 |
| 55 |
ERYTHEMA INFECTIOSUM |
1 |
0.0039 |
| 56 |
OEDEMATOUS KIDNEY |
1 |
0.0038 |
| 57 |
CHOLANGITIS INFECTIVE |
1 |
0.0038 |
| 58 |
MEASLES |
2 |
0.0037 |
| 59 |
CHRONIC HEPATITIS |
3 |
0.0037 |
| 60 |
ANTITHROMBIN III DECREASED |
1 |
0.0037 |
| 61 |
INTESTINAL DIAPHRAGM DISEASE |
1 |
0.0036 |
| 62 |
BILE ACID MALABSORPTION |
1 |
0.0035 |
| 63 |
DILATATION INTRAHEPATIC DUCT ACQUIRED |
1 |
0.0034 |
| 64 |
ALOPECIA UNIVERSALIS |
1 |
0.0034 |
| 65 |
CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION |
1 |
0.0034 |
| 66 |
HISTOPLASMOSIS DISSEMINATED |
5 |
0.0031 |
| 67 |
NODULAR REGENERATIVE HYPERPLASIA |
2 |
0.0031 |
| 68 |
INTESTINAL ANASTOMOSIS |
2 |
0.0031 |
| 69 |
VULVITIS |
1 |
0.0030 |
| 70 |
ILEOCAECAL RESECTION |
1 |
0.0029 |
| 71 |
RHINOCEREBRAL MUCORMYCOSIS |
1 |
0.0029 |
| 72 |
ANASTOMOTIC LEAK |
2 |
0.0029 |
| 73 |
GASTROINTESTINAL MICROORGANISM OVERGROWTH |
1 |
0.0028 |
| 74 |
CYTOMEGALOVIRUS HEPATITIS |
1 |
0.0028 |
| 75 |
PSEUDOPOLYP |
1 |
0.0028 |
| 76 |
SPLENIC LESION |
1 |
0.0027 |
| 77 |
HEPATOSPLENIC T-CELL LYMPHOMA |
1 |
0.0027 |
| 78 |
HUMAN RHINOVIRUS TEST POSITIVE |
1 |
0.0027 |
| 79 |
PENILE ERYTHEMA |
1 |
0.0027 |
| 80 |
VIRAL MYOCARDITIS |
1 |
0.0027 |
| 81 |
PARVOVIRUS INFECTION |
1 |
0.0025 |
| 82 |
ATYPICAL HAEMOLYTIC URAEMIC SYNDROME |
2 |
0.0025 |
| 83 |
BLOOD PRODUCT TRANSFUSION DEPENDENT |
1 |
0.0024 |
| 84 |
METASTASES TO PANCREAS |
1 |
0.0023 |
| 85 |
ANAEMIA MEGALOBLASTIC |
1 |
0.0022 |
| 86 |
PNEUMATOSIS |
1 |
0.0022 |
| 87 |
MANUFACTURING ISSUE |
1 |
0.0022 |
| 88 |
CENTRAL VENOUS CATHETER REMOVAL |
1 |
0.0021 |
| 89 |
MECHANICAL URTICARIA |
1 |
0.0021 |
| 90 |
MINIMAL RESIDUAL DISEASE |
1 |
0.0021 |
| 91 |
ORAL CAVITY FISTULA |
1 |
0.0020 |
| 92 |
HYPOFIBRINOGENAEMIA |
2 |
0.0020 |
| 93 |
NEONATAL RESPIRATORY FAILURE |
1 |
0.0020 |
| 94 |
SPLENIC HAEMORRHAGE |
1 |
0.0020 |
| 95 |
HYPERLIPASAEMIA |
1 |
0.0019 |
| 96 |
HEPATITIS E |
3 |
0.0019 |
| 97 |
TRANSVERSE SINUS THROMBOSIS |
1 |
0.0019 |
| 98 |
DRUG LEVEL ABNORMAL |
1 |
0.0019 |
| 99 |
HYPERTRIGLYCERIDAEMIA |
11 |
0.0019 |
| 100 |
HYPERTROPHY |
1 |
0.0018 |
| 101 |
EPSTEIN-BARR VIRAEMIA |
2 |
0.0018 |
| 102 |
KLEBSIELLA SEPSIS |
2 |
0.0018 |
| 103 |
TRANSAMINASES ABNORMAL |
1 |
0.0017 |
| 104 |
PSEUDOMONAL SEPSIS |
3 |
0.0017 |
| 105 |
DOSE CALCULATION ERROR |
1 |
0.0017 |
| 106 |
CEREBRAL ASPERGILLOSIS |
1 |
0.0016 |
| 107 |
PROTHROMBIN TIME RATIO DECREASED |
1 |
0.0016 |
| 108 |
ANAL INFLAMMATION |
1 |
0.0016 |
| 109 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
4 |
0.0015 |
| 110 |
SMALL INTESTINE ULCER |
1 |
0.0015 |
| 111 |
TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA |
1 |
0.0015 |
| 112 |
OESOPHAGITIS ULCERATIVE |
1 |
0.0015 |
| 113 |
ARACHNOIDITIS |
1 |
0.0014 |
| 114 |
PULMONARY VENO-OCCLUSIVE DISEASE |
1 |
0.0014 |
| 115 |
RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE |
1 |
0.0014 |
| 116 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
4 |
0.0014 |
| 117 |
PERINEAL PAIN |
1 |
0.0014 |
| 118 |
INFECTION IN AN IMMUNOCOMPROMISED HOST |
1 |
0.0014 |
| 119 |
PNEUMONIA PNEUMOCOCCAL |
2 |
0.0013 |
| 120 |
GASTROINTESTINAL WALL THICKENING |
2 |
0.0013 |
| 121 |
EXPOSURE TO COMMUNICABLE DISEASE |
1 |
0.0013 |
| 122 |
TRACHEITIS |
1 |
0.0013 |
| 123 |
COAGULATION TEST ABNORMAL |
1 |
0.0013 |
| 124 |
PORTAL HYPERTENSION |
4 |
0.0013 |
| 125 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
3 |
0.0013 |
| 126 |
PANCREATIC PSEUDOCYST |
1 |
0.0013 |
| 127 |
BREAST FEEDING |
1 |
0.0013 |
| 128 |
INTESTINAL ULCER |
2 |
0.0013 |
| 129 |
SUPERIOR SAGITTAL SINUS THROMBOSIS |
1 |
0.0013 |
| 130 |
RENAL ABSCESS |
1 |
0.0012 |
| 131 |
HAND-FOOT-AND-MOUTH DISEASE |
1 |
0.0012 |
| 132 |
ADRENAL MASS |
1 |
0.0012 |
| 133 |
CAMPYLOBACTER INFECTION |
1 |
0.0012 |
| 134 |
VENOOCCLUSIVE DISEASE |
3 |
0.0012 |
| 135 |
PERITONSILLAR ABSCESS |
1 |
0.0012 |
| 136 |
LUNG OPERATION |
1 |
0.0012 |
| 137 |
POTENTIATING DRUG INTERACTION |
4 |
0.0012 |
| 138 |
LEUKAEMIA RECURRENT |
2 |
0.0012 |
| 139 |
PULMONARY CAVITATION |
1 |
0.0011 |
| 140 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
2 |
0.0011 |
| 141 |
PAPILLARY THYROID CANCER |
2 |
0.0011 |
| 142 |
JUGULAR VEIN THROMBOSIS |
2 |
0.0011 |
| 143 |
MUCOSAL EROSION |
1 |
0.0011 |
| 144 |
HEPATOTOXICITY |
24 |
0.0011 |
| 145 |
BLOOD ALKALINE PHOSPHATASE DECREASED |
1 |
0.0011 |
| 146 |
BICYTOPENIA |
2 |
0.0010 |
| 147 |
STAPHYLOCOCCAL SEPSIS |
5 |
0.0010 |
| 148 |
VENOOCCLUSIVE LIVER DISEASE |
5 |
0.0010 |
| 149 |
MUCOSAL ULCERATION |
1 |
0.0010 |
| 150 |
AUTISM |
1 |
0.0010 |
| 151 |
ACUTE PROMYELOCYTIC LEUKAEMIA |
1 |
0.0010 |
| 152 |
POST LUMBAR PUNCTURE SYNDROME |
1 |
0.0010 |
| 153 |
CYTOGENETIC ANALYSIS ABNORMAL |
1 |
0.0010 |
| 154 |
STAPHYLOCOCCUS TEST POSITIVE |
2 |
0.0009 |
| 155 |
SMALL INTESTINAL STENOSIS |
1 |
0.0009 |
| 156 |
KETOSIS |
1 |
0.0009 |
| 157 |
OESOPHAGEAL VARICES HAEMORRHAGE |
2 |
0.0009 |
| 158 |
PERIRECTAL ABSCESS |
1 |
0.0009 |
| 159 |
NEOPLASM RECURRENCE |
3 |
0.0009 |
| 160 |
PULMONARY GRANULOMA |
1 |
0.0009 |
| 161 |
CORTISOL DECREASED |
1 |
0.0009 |
| 162 |
PANCREATITIS NECROTISING |
2 |
0.0009 |
| 163 |
CYTOMEGALOVIRUS COLITIS |
2 |
0.0009 |
| 164 |
SYSTEMIC MYCOSIS |
1 |
0.0009 |
| 165 |
PROCALCITONIN INCREASED |
1 |
0.0009 |
| 166 |
ESCHERICHIA BACTERAEMIA |
2 |
0.0008 |
| 167 |
PHYSICAL PRODUCT LABEL ISSUE |
1 |
0.0008 |
| 168 |
BILE DUCT STENOSIS |
1 |
0.0008 |
| 169 |
PHARYNGEAL INFLAMMATION |
1 |
0.0008 |
| 170 |
MONOCYTE COUNT DECREASED |
1 |
0.0008 |
| 171 |
OTITIS EXTERNA |
1 |
0.0008 |
| 172 |
LARGE INTESTINE INFECTION |
1 |
0.0008 |
| 173 |
HEPATIC INFECTION |
1 |
0.0008 |
| 174 |
ILEOSTOMY |
2 |
0.0008 |
| 175 |
BLOOD BILIRUBIN ABNORMAL |
1 |
0.0008 |
| 176 |
RHINOVIRUS INFECTION |
3 |
0.0008 |
| 177 |
APLASTIC ANAEMIA |
4 |
0.0008 |
| 178 |
GASTROENTERITIS NOROVIRUS |
1 |
0.0008 |
| 179 |
LIP EXFOLIATION |
1 |
0.0008 |
| 180 |
CHEILITIS |
4 |
0.0007 |
| 181 |
STENOTROPHOMONAS INFECTION |
1 |
0.0007 |
| 182 |
SIALOADENITIS |
1 |
0.0007 |
| 183 |
URETERIC OBSTRUCTION |
1 |
0.0007 |
| 184 |
EFFUSION |
1 |
0.0007 |
| 185 |
MENINGITIS VIRAL |
1 |
0.0007 |
| 186 |
CHOLECYSTITIS INFECTIVE |
2 |
0.0007 |
| 187 |
PROCTITIS |
2 |
0.0007 |
| 188 |
PROTHROMBIN TIME SHORTENED |
1 |
0.0007 |
| 189 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
1 |
0.0007 |
| 190 |
HEPATOCELLULAR INJURY |
10 |
0.0007 |
| 191 |
BLOOD ELECTROLYTES DECREASED |
1 |
0.0007 |
| 192 |
NEUTROPENIC SEPSIS |
5 |
0.0007 |
| 193 |
BLADDER TRANSITIONAL CELL CARCINOMA |
1 |
0.0007 |
| 194 |
PRODUCT MONITORING ERROR |
1 |
0.0007 |
| 195 |
ESCHERICHIA SEPSIS |
2 |
0.0007 |
| 196 |
ADENOVIRUS INFECTION |
2 |
0.0007 |
| 197 |
BONE MARROW FAILURE |
14 |
0.0007 |
| 198 |
PANCREATIC ENZYMES INCREASED |
1 |
0.0007 |
| 199 |
ACUTE ABDOMEN |
1 |
0.0007 |
| 200 |
NORMOCYTIC ANAEMIA |
1 |
0.0007 |
| 201 |
BILIARY DILATATION |
1 |
0.0007 |
| 202 |
CHOLESTASIS |
13 |
0.0007 |
| 203 |
HYPERBILIRUBINAEMIA |
7 |
0.0007 |
| 204 |
HISTIOCYTOSIS HAEMATOPHAGIC |
2 |
0.0007 |
| 205 |
PELVIC INFLAMMATORY DISEASE |
1 |
0.0007 |
| 206 |
BONE MARROW DISORDER |
2 |
0.0007 |
| 207 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
1 |
0.0007 |
| 208 |
HYPOALBUMINAEMIA |
5 |
0.0006 |
| 209 |
PRODUCT DEPOSIT |
1 |
0.0006 |
| 210 |
EPSTEIN-BARR VIRUS INFECTION |
4 |
0.0006 |
| 211 |
ONYCHOLYSIS |
1 |
0.0006 |
| 212 |
MEGACOLON |
1 |
0.0006 |
| 213 |
PNEUMONIA VIRAL |
2 |
0.0006 |
| 214 |
RECTAL ABSCESS |
1 |
0.0006 |
| 215 |
FEMALE GENITAL TRACT FISTULA |
1 |
0.0006 |
| 216 |
HEPATIC FIBROSIS |
2 |
0.0006 |
| 217 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
5 |
0.0006 |
| 218 |
SPINAL CORD INJURY |
1 |
0.0006 |
| 219 |
ALOPECIA AREATA |
1 |
0.0006 |
| 220 |
LYMPHOPENIA |
8 |
0.0006 |
| 221 |
HISTOPLASMOSIS |
1 |
0.0006 |
| 222 |
DRUG MONITORING PROCEDURE NOT PERFORMED |
1 |
0.0006 |
| 223 |
ANAL ABSCESS |
3 |
0.0006 |
| 224 |
CUTANEOUS VASCULITIS |
2 |
0.0005 |
| 225 |
BODY TEMPERATURE ABNORMAL |
1 |
0.0005 |
| 226 |
CEREBROSPINAL FLUID LEAKAGE |
1 |
0.0005 |
| 227 |
DIFFUSE ALOPECIA |
1 |
0.0005 |
| 228 |
LYMPH NODE PAIN |
1 |
0.0005 |
| 229 |
STENOSIS |
1 |
0.0005 |
| 230 |
INTERVERTEBRAL DISCITIS |
1 |
0.0005 |
| 231 |
HYPOGLYCAEMIA |
25 |
0.0005 |
| 232 |
CAESAREAN SECTION |
6 |
0.0005 |
| 233 |
PNEUMONIA CYTOMEGALOVIRAL |
1 |
0.0005 |
| 234 |
APLASIA |
1 |
0.0005 |
| 235 |
CELL DEATH |
1 |
0.0005 |
| 236 |
LOW BIRTH WEIGHT BABY |
4 |
0.0005 |
| 237 |
ANORECTAL DISORDER |
1 |
0.0005 |
| 238 |
LARGE INTESTINAL STENOSIS |
1 |
0.0005 |
| 239 |
DEVICE RELATED SEPSIS |
1 |
0.0005 |
| 240 |
MUCOSAL INFLAMMATION |
13 |
0.0005 |
| 241 |
NEUTROPHIL COUNT INCREASED |
5 |
0.0005 |
| 242 |
RENAL MASS |
1 |
0.0005 |
| 243 |
ATRIAL THROMBOSIS |
1 |
0.0005 |
| 244 |
VARICELLA ZOSTER VIRUS INFECTION |
1 |
0.0005 |
| 245 |
ALANINE AMINOTRANSFERASE ABNORMAL |
1 |
0.0005 |
| 246 |
TORTICOLLIS |
1 |
0.0005 |
| 247 |
FOETAL DISTRESS SYNDROME |
1 |
0.0005 |
| 248 |
ESCHERICHIA URINARY TRACT INFECTION |
2 |
0.0005 |
| 249 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
1 |
0.0005 |
| 250 |
OCULAR ICTERUS |
2 |
0.0005 |
| 251 |
GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0005 |
| 252 |
DISEASE COMPLICATION |
2 |
0.0004 |
| 253 |
BREAKTHROUGH PAIN |
1 |
0.0004 |
| 254 |
HAEMOLYTIC URAEMIC SYNDROME |
1 |
0.0004 |
| 255 |
PANCYTOPENIA |
24 |
0.0004 |
| 256 |
RESPIRATORY TRACT INFECTION VIRAL |
1 |
0.0004 |
| 257 |
DIARRHOEA HAEMORRHAGIC |
4 |
0.0004 |
| 258 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
1 |
0.0004 |
| 259 |
CYTOMEGALOVIRUS INFECTION |
7 |
0.0004 |
| 260 |
HAEMATOTOXICITY |
4 |
0.0004 |
| 261 |
HAEMATOLOGICAL INFECTION |
1 |
0.0004 |
| 262 |
BLOOD IMMUNOGLOBULIN G DECREASED |
1 |
0.0004 |
| 263 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
3 |
0.0004 |
| 264 |
URINARY TRACT INFECTION BACTERIAL |
1 |
0.0004 |
| 265 |
BRAIN ABSCESS |
1 |
0.0004 |
| 266 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
2 |
0.0004 |
| 267 |
LIPASE INCREASED |
3 |
0.0004 |
| 268 |
PRODUCT COLOUR ISSUE |
2 |
0.0004 |
| 269 |
MUCORMYCOSIS |
1 |
0.0004 |
| 270 |
FULL BLOOD COUNT ABNORMAL |
4 |
0.0004 |
| 271 |
FEBRILE NEUTROPENIA |
25 |
0.0004 |
| 272 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 273 |
ANIMAL BITE |
1 |
0.0004 |
| 274 |
RHINITIS |
3 |
0.0004 |
| 275 |
LARGE INTESTINAL ULCER |
1 |
0.0004 |
| 276 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0004 |
| 277 |
ANAL HAEMORRHAGE |
1 |
0.0004 |
| 278 |
COLECTOMY |
2 |
0.0004 |
| 279 |
IMMUNE THROMBOCYTOPENIC PURPURA |
1 |
0.0004 |
| 280 |
CEREBRAL THROMBOSIS |
1 |
0.0004 |
| 281 |
LIP PAIN |
1 |
0.0003 |
| 282 |
IMMUNOSUPPRESSION |
3 |
0.0003 |
| 283 |
PROTHROMBIN TIME PROLONGED |
2 |
0.0003 |
| 284 |
MIXED LIVER INJURY |
1 |
0.0003 |
| 285 |
CENTRAL VENOUS CATHETERISATION |
1 |
0.0003 |
| 286 |
BLOOD COUNT ABNORMAL |
5 |
0.0003 |
| 287 |
INTRACARDIAC THROMBUS |
1 |
0.0003 |
| 288 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0003 |
| 289 |
BLOOD CREATININE DECREASED |
1 |
0.0003 |
| 290 |
ABDOMINAL ADHESIONS |
1 |
0.0003 |
| 291 |
FAECAL CALPROTECTIN INCREASED |
1 |
0.0003 |
| 292 |
ENTERITIS |
2 |
0.0003 |
| 293 |
PANCREATITIS ACUTE |
7 |
0.0003 |
| 294 |
PROCTALGIA |
2 |
0.0003 |
| 295 |
PORTAL VEIN THROMBOSIS |
1 |
0.0003 |
| 296 |
LIVER ABSCESS |
1 |
0.0003 |
| 297 |
BACTERIAL SEPSIS |
1 |
0.0003 |
| 298 |
HYPOVENTILATION |
1 |
0.0003 |
| 299 |
THERAPY CHANGE |
3 |
0.0003 |
| 300 |
ASPERGILLUS INFECTION |
2 |
0.0003 |
| 301 |
OFF LABEL USE |
266 |
0.0003 |
| 302 |
OTITIS MEDIA |
1 |
0.0003 |
| 303 |
VIRAL INFECTION |
10 |
0.0003 |
| 304 |
COAGULOPATHY |
5 |
0.0003 |
| 305 |
NEUTROPHIL COUNT DECREASED |
12 |
0.0003 |
| 306 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
1 |
0.0003 |
| 307 |
HYPERTRANSAMINASAEMIA |
2 |
0.0003 |
| 308 |
ERYTHEMA NODOSUM |
1 |
0.0003 |
| 309 |
JAUNDICE CHOLESTATIC |
1 |
0.0003 |
| 310 |
APPENDICECTOMY |
1 |
0.0003 |
| 311 |
LEUKOPENIA |
14 |
0.0003 |
| 312 |
AMYLASE INCREASED |
1 |
0.0003 |
| 313 |
TRANSAMINASES INCREASED |
6 |
0.0003 |
| 314 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
1 |
0.0003 |
| 315 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 316 |
HEPATIC NECROSIS |
1 |
0.0003 |
| 317 |
CHEMOTHERAPY |
1 |
0.0003 |
| 318 |
CATHETER SITE INFECTION |
1 |
0.0003 |
| 319 |
ALANINE AMINOTRANSFERASE INCREASED |
16 |
0.0003 |
| 320 |
DEVICE RELATED INFECTION |
4 |
0.0003 |
| 321 |
BLOOD BILIRUBIN INCREASED |
7 |
0.0003 |
| 322 |
PULMONARY HAEMORRHAGE |
2 |
0.0003 |
| 323 |
DRUG-INDUCED LIVER INJURY |
8 |
0.0003 |
| 324 |
AFFECTIVE DISORDER |
2 |
0.0003 |
| 325 |
RESPIRATORY DISTRESS |
7 |
0.0003 |
| 326 |
BLOOD ALBUMIN DECREASED |
2 |
0.0003 |
| 327 |
HYPERLIPIDAEMIA |
3 |
0.0003 |
| 328 |
SKIN PAPILLOMA |
1 |
0.0002 |
| 329 |
CYSTITIS HAEMORRHAGIC |
1 |
0.0002 |
| 330 |
FUNGAL SKIN INFECTION |
1 |
0.0002 |
| 331 |
ADRENAL INSUFFICIENCY |
3 |
0.0002 |
| 332 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
1 |
0.0002 |
| 333 |
PANCREATITIS |
13 |
0.0002 |
| 334 |
SMALL INTESTINAL OBSTRUCTION |
3 |
0.0002 |
| 335 |
HYPERAESTHESIA |
2 |
0.0002 |
| 336 |
EXPOSURE DURING PREGNANCY |
15 |
0.0002 |
| 337 |
EXPIRED PRODUCT ADMINISTERED |
8 |
0.0002 |
| 338 |
PURULENT DISCHARGE |
1 |
0.0002 |
| 339 |
PSEUDOMONAS INFECTION |
2 |
0.0002 |
| 340 |
CARDIAC OPERATION |
2 |
0.0002 |
| 341 |
HEPATIC LESION |
1 |
0.0002 |
| 342 |
STAPHYLOCOCCAL BACTERAEMIA |
1 |
0.0002 |
| 343 |
NEUROTOXICITY |
4 |
0.0002 |
| 344 |
MELANOCYTIC NAEVUS |
1 |
0.0002 |
| 345 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
1 |
0.0002 |
| 346 |
ABDOMINAL ABSCESS |
1 |
0.0002 |
| 347 |
ILEUS PARALYTIC |
1 |
0.0002 |
| 348 |
HAEMOLYTIC ANAEMIA |
2 |
0.0002 |
| 349 |
IRON DEFICIENCY |
1 |
0.0002 |
| 350 |
LUPUS-LIKE SYNDROME |
2 |
0.0002 |
| 351 |
HEPATIC ENCEPHALOPATHY |
2 |
0.0002 |
| 352 |
COLITIS MICROSCOPIC |
1 |
0.0002 |
| 353 |
PRE-ECLAMPSIA |
1 |
0.0002 |
| 354 |
ENTEROCOCCAL INFECTION |
1 |
0.0002 |
| 355 |
SEPTIC SHOCK |
9 |
0.0002 |
| 356 |
INFLAMMATORY BOWEL DISEASE |
2 |
0.0002 |
| 357 |
ORGANISING PNEUMONIA |
1 |
0.0002 |
| 358 |
COLITIS ULCERATIVE |
9 |
0.0002 |
| 359 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
2 |
0.0002 |
| 360 |
TOXIC SKIN ERUPTION |
2 |
0.0002 |
| 361 |
PRODUCT SOLUBILITY ABNORMAL |
1 |
0.0002 |
| 362 |
STOMATITIS |
12 |
0.0002 |
| 363 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 364 |
AMMONIA INCREASED |
1 |
0.0002 |
| 365 |
CEREBRAL ISCHAEMIA |
1 |
0.0002 |
| 366 |
PETECHIAE |
2 |
0.0002 |
| 367 |
TONSILLITIS |
1 |
0.0002 |
| 368 |
HEPATIC ENZYME INCREASED |
13 |
0.0002 |
| 369 |
SERUM FERRITIN INCREASED |
1 |
0.0002 |
| 370 |
CLOSTRIDIUM DIFFICILE COLITIS |
2 |
0.0002 |
| 371 |
PREMATURE DELIVERY |
3 |
0.0002 |
| 372 |
ANAL FISTULA |
1 |
0.0002 |
| 373 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
4 |
0.0002 |
| 374 |
SKIN INFECTION |
2 |
0.0002 |
| 375 |
PRODUCT LEAKAGE |
1 |
0.0002 |
| 376 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 377 |
EXERCISE TOLERANCE DECREASED |
1 |
0.0002 |
| 378 |
SKIN WARM |
1 |
0.0002 |
| 379 |
BACTERAEMIA |
2 |
0.0002 |
| 380 |
CHOLECYSTITIS |
2 |
0.0002 |
| 381 |
ODYNOPHAGIA |
1 |
0.0002 |
| 382 |
FOETAL GROWTH RESTRICTION |
1 |
0.0002 |
| 383 |
DERMATITIS ACNEIFORM |
1 |
0.0002 |
| 384 |
NEUTROPENIA |
22 |
0.0002 |
| 385 |
PHARYNGITIS |
2 |
0.0002 |
| 386 |
OLIGURIA |
1 |
0.0002 |
| 387 |
HEPATIC STEATOSIS |
3 |
0.0002 |
| 388 |
BACTERIAL INFECTION |
3 |
0.0002 |
| 389 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 390 |
IMMUNE SYSTEM DISORDER |
2 |
0.0002 |
| 391 |
PRODUCT FORMULATION ISSUE |
1 |
0.0002 |
| 392 |
EAR INFECTION |
4 |
0.0002 |
| 393 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
1 |
0.0001 |
| 394 |
GINGIVAL BLEEDING |
2 |
0.0001 |
| 395 |
ACUTE HEPATIC FAILURE |
2 |
0.0001 |
| 396 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 397 |
ENCEPHALITIS |
1 |
0.0001 |
| 398 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
4 |
0.0001 |
| 399 |
METASTASIS |
1 |
0.0001 |
| 400 |
MYELODYSPLASTIC SYNDROME |
2 |
0.0001 |
| 401 |
CLOSTRIDIUM DIFFICILE INFECTION |
3 |
0.0001 |
| 402 |
GASTROENTERITIS |
2 |
0.0001 |
| 403 |
ACCIDENTAL OVERDOSE |
5 |
0.0001 |
| 404 |
MOUTH HAEMORRHAGE |
1 |
0.0001 |
| 405 |
THROMBOCYTOPENIA |
15 |
0.0001 |
| 406 |
ASPARTATE AMINOTRANSFERASE INCREASED |
7 |
0.0001 |
| 407 |
SHOCK |
3 |
0.0001 |
| 408 |
DIFFUSE LARGE B-CELL LYMPHOMA |
1 |
0.0001 |
| 409 |
PERICARDIAL EFFUSION |
3 |
0.0001 |
| 410 |
HAEMOLYSIS |
1 |
0.0001 |
| 411 |
APHTHOUS ULCER |
1 |
0.0001 |
| 412 |
LUNG INFECTION |
2 |
0.0001 |
| 413 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
1 |
0.0001 |
| 414 |
ACUTE MYELOID LEUKAEMIA |
2 |
0.0001 |
| 415 |
GASTROINTESTINAL INFLAMMATION |
1 |
0.0001 |
| 416 |
FURUNCLE |
1 |
0.0001 |
| 417 |
NASAL DISCOMFORT |
1 |
0.0001 |
| 418 |
UTERINE CANCER |
1 |
0.0001 |
| 419 |
FOETAL EXPOSURE DURING PREGNANCY |
10 |
0.0001 |
| 420 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 421 |
PYREXIA |
42 |
0.0001 |
| 422 |
PHOTOSENSITIVITY REACTION |
2 |
0.0001 |
| 423 |
GENERALISED TONIC-CLONIC SEIZURE |
2 |
0.0001 |
| 424 |
SECOND PRIMARY MALIGNANCY |
1 |
0.0001 |
| 425 |
FUNGAL INFECTION |
4 |
0.0001 |
| 426 |
CANDIDA INFECTION |
2 |
0.0001 |
| 427 |
MYOPATHY |
1 |
0.0001 |
| 428 |
LYMPHOCYTE COUNT DECREASED |
2 |
0.0001 |
| 429 |
CARDIOTOXICITY |
1 |
0.0001 |
| 430 |
ABDOMINAL PAIN |
26 |
0.0001 |
| 431 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
5 |
0.0001 |
| 432 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 433 |
MYELOSUPPRESSION |
4 |
0.0001 |
| 434 |
ANAPHYLACTIC REACTION |
6 |
0.0001 |
| 435 |
IRON DEFICIENCY ANAEMIA |
1 |
0.0001 |
| 436 |
AGRANULOCYTOSIS |
2 |
0.0001 |
| 437 |
MIDDLE INSOMNIA |
2 |
0.0001 |
| 438 |
LACERATION |
1 |
0.0001 |
| 439 |
SQUAMOUS CELL CARCINOMA |
1 |
0.0001 |
| 440 |
SPINAL DISORDER |
1 |
0.0001 |
| 441 |
COLITIS |
4 |
0.0001 |
| 442 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1 |
0.0001 |
| 443 |
SEIZURE |
12 |
0.0001 |
| 444 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 445 |
DRUG INTOLERANCE |
10 |
0.0001 |
| 446 |
ORAL HERPES |
2 |
0.0001 |
| 447 |
ASCITES |
3 |
0.0001 |
| 448 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 449 |
HAEMATOCRIT DECREASED |
2 |
0.0001 |
| 450 |
ADVERSE DRUG REACTION |
9 |
0.0001 |
| 451 |
CYTOKINE RELEASE SYNDROME |
2 |
0.0001 |
| 452 |
PREMATURE BABY |
3 |
0.0001 |
| 453 |
FULL BLOOD COUNT DECREASED |
2 |
0.0001 |
| 454 |
PERITONITIS BACTERIAL |
1 |
0.0001 |
| 455 |
PRODUCT ADMINISTRATION ERROR |
2 |
0.0001 |
| 456 |
HYPOTHERMIA |
1 |
0.0001 |
| 457 |
SEPSIS |
11 |
0.0001 |
| 458 |
SLUGGISHNESS |
1 |
0.0001 |
| 459 |
PERITONITIS |
2 |
0.0001 |
| 460 |
PRODUCT ODOUR ABNORMAL |
1 |
0.0001 |
| 461 |
FOLLICULITIS |
1 |
0.0001 |
| 462 |
MOUTH ULCERATION |
2 |
0.0001 |
| 463 |
SCRATCH |
1 |
0.0001 |
| 464 |
RECTAL HAEMORRHAGE |
4 |
0.0001 |
| 465 |
NIGHT SWEATS |
3 |
0.0001 |
| 466 |
POOR QUALITY SLEEP |
2 |
0.0001 |
| 467 |
CHOLELITHIASIS |
3 |
0.0001 |
| 468 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
5 |
0.0001 |
| 469 |
MALNUTRITION |
1 |
0.0001 |
| 470 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 471 |
CHROMATURIA |
2 |
0.0001 |
| 472 |
MYOCARDITIS |
1 |
0.0001 |
| 473 |
METASTASES TO LUNG |
1 |
0.0001 |
| 474 |
SPLENOMEGALY |
1 |
0.0001 |
| 475 |
VOMITING |
40 |
0.0001 |
| 476 |
LYMPHADENOPATHY |
3 |
0.0001 |
| 477 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 478 |
PRODUCT PRESCRIBING ERROR |
2 |
0.0001 |
| 479 |
POLYNEUROPATHY |
1 |
0.0001 |
| 480 |
SKIN EXFOLIATION |
7 |
0.0001 |
| 481 |
NOCTURIA |
1 |
0.0001 |
| 482 |
NEURALGIA |
2 |
0.0001 |
| 483 |
CYTOPENIA |
1 |
0.0001 |
| 484 |
LIVER INJURY |
2 |
0.0001 |
| 485 |
ENCEPHALOPATHY |
2 |
0.0001 |
| 486 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 487 |
HEPATIC FUNCTION ABNORMAL |
3 |
0.0001 |
| 488 |
EPISTAXIS |
6 |
0.0001 |
| 489 |
HAEMATEMESIS |
2 |
0.0001 |
| 490 |
HEPATIC CYTOLYSIS |
1 |
0.0001 |
| 491 |
HEPATITIS |
2 |
0.0001 |
| 492 |
THERAPY CESSATION |
4 |
0.0001 |
| 493 |
HAEMOGLOBIN DECREASED |
8 |
0.0001 |
| 494 |
DRUG RESISTANCE |
2 |
0.0001 |
| 495 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
| 496 |
INFECTION |
11 |
0.0001 |
| 497 |
FREQUENT BOWEL MOVEMENTS |
2 |
0.0001 |
| 498 |
WHITE BLOOD CELL COUNT DECREASED |
8 |
0.0001 |
| 499 |
TACHYPNOEA |
1 |
0.0001 |
| 500 |
TREATMENT FAILURE |
6 |
0.0001 |
| 501 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 502 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 503 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 504 |
LIVER FUNCTION TEST ABNORMAL |
2 |
0.0001 |
| 505 |
LIVER DISORDER |
3 |
0.0001 |
| 506 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 507 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 508 |
GASTROINTESTINAL DISORDER |
6 |
0.0001 |
| 509 |
THERAPY NON-RESPONDER |
3 |
0.0001 |
| 510 |
CONTRAINDICATED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 511 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 512 |
UPPER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 513 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 514 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 515 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 516 |
ANAEMIA |
12 |
0.0001 |
| 517 |
ULCER |
1 |
0.0001 |
| 518 |
METABOLIC ACIDOSIS |
2 |
0.0001 |
| 519 |
CARDIAC FAILURE |
5 |
0.0001 |
| 520 |
BACK DISORDER |
1 |
0.0001 |
| 521 |
IMPAIRED HEALING |
2 |
0.0001 |
| 522 |
OSTEONECROSIS |
2 |
0.0001 |
| 523 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 524 |
DRUG LEVEL INCREASED |
1 |
0.0001 |
| 525 |
PERICARDITIS |
1 |
0.0001 |
| 526 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 527 |
PRODUCT STORAGE ERROR |
5 |
0.0001 |
| 528 |
EOSINOPHILIA |
1 |
0.0001 |
| 529 |
HYPERKALAEMIA |
2 |
0.0001 |
| 530 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 531 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 532 |
PLATELET COUNT DECREASED |
6 |
0.0001 |
| 533 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 534 |
CEREBRAL HAEMORRHAGE |
2 |
0.0001 |
| 535 |
PELVIC PAIN |
1 |
0.0001 |
| 536 |
RESPIRATORY FAILURE |
4 |
0.0001 |
| 537 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 538 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 539 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 540 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 541 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 542 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 543 |
HOSPITALISATION |
8 |
0.0001 |
| 544 |
DECREASED APPETITE |
12 |
0.0001 |
| 545 |
SKIN FISSURES |
1 |
0.0001 |
| 546 |
ABORTION SPONTANEOUS |
2 |
0.0000 |
| 547 |
FEEDING DISORDER |
1 |
0.0000 |
| 548 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 549 |
GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0000 |
| 550 |
DERMATITIS |
1 |
0.0000 |
| 551 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 552 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 553 |
SKIN CANCER |
1 |
0.0000 |
| 554 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 555 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 556 |
MELAENA |
1 |
0.0000 |
| 557 |
ANGIOEDEMA |
2 |
0.0000 |
| 558 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 559 |
RASH PAPULAR |
1 |
0.0000 |
| 560 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 561 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 562 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 563 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 564 |
THERAPY INTERRUPTED |
3 |
0.0000 |
| 565 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 566 |
LUNG DISORDER |
2 |
0.0000 |
| 567 |
PNEUMONIA |
13 |
0.0000 |
| 568 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 569 |
ACUTE KIDNEY INJURY |
6 |
0.0000 |
| 570 |
RASH |
17 |
0.0000 |
| 571 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 572 |
RASH GENERALISED |
1 |
0.0000 |
| 573 |
DIPLOPIA |
1 |
0.0000 |
| 574 |
NAUSEA |
30 |
0.0000 |
| 575 |
DRUG INTERACTION |
6 |
0.0000 |
| 576 |
HYPERSENSITIVITY |
7 |
0.0000 |
| 577 |
BRADYCARDIA |
2 |
0.0000 |
| 578 |
JAUNDICE |
1 |
0.0000 |
| 579 |
OVERDOSE |
8 |
0.0000 |
| 580 |
PALLOR |
1 |
0.0000 |
| 581 |
PNEUMONITIS |
1 |
0.0000 |
| 582 |
SKIN LESION |
1 |
0.0000 |
| 583 |
PRODUCT USE IN UNAPPROVED INDICATION |
9 |
0.0000 |
| 584 |
MEDICATION ERROR |
2 |
0.0000 |
| 585 |
INFLUENZA |
4 |
0.0000 |
| 586 |
ALOPECIA |
7 |
0.0000 |
| 587 |
BLISTER |
2 |
0.0000 |
| 588 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 589 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 590 |
TACHYCARDIA |
3 |
0.0000 |
| 591 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 592 |
HEPATIC FAILURE |
1 |
0.0000 |
| 593 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 594 |
VERTIGO |
2 |
0.0000 |
| 595 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 596 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
| 597 |
HIP FRACTURE |
1 |
0.0000 |
| 598 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 599 |
SKIN DISORDER |
1 |
0.0000 |
| 600 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 601 |
SINUSITIS |
3 |
0.0000 |
| 602 |
GASTRIC DISORDER |
1 |
0.0000 |
| 603 |
COVID-19 |
5 |
0.0000 |
| 604 |
HYPOXIA |
1 |
0.0000 |
| 605 |
DYSURIA |
1 |
0.0000 |
| 606 |
BRONCHITIS |
2 |
0.0000 |
| 607 |
EYE SWELLING |
1 |
0.0000 |
| 608 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 609 |
DIARRHOEA |
17 |
0.0000 |
| 610 |
GENERAL PHYSICAL HEALTH DETERIORATION |
3 |
0.0000 |
| 611 |
CHILLS |
3 |
0.0000 |
| 612 |
DISEASE PROGRESSION |
3 |
0.0000 |
| 613 |
THROMBOSIS |
2 |
0.0000 |
| 614 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 615 |
DYSKINESIA |
1 |
0.0000 |
| 616 |
ABDOMINAL PAIN UPPER |
5 |
0.0000 |
| 617 |
ABDOMINAL DISCOMFORT |
4 |
0.0000 |
| 618 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 619 |
RENAL FAILURE |
3 |
0.0000 |
| 620 |
MATERNAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 621 |
THROAT IRRITATION |
1 |
0.0000 |
| 622 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 623 |
TINNITUS |
1 |
0.0000 |
| 624 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 625 |
PRODUCT USE ISSUE |
4 |
0.0000 |
| 626 |
DYSPHAGIA |
2 |
0.0000 |
| 627 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 628 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 629 |
CONTUSION |
2 |
0.0000 |
| 630 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 631 |
SYNCOPE |
2 |
0.0000 |
| 632 |
CONDITION AGGRAVATED |
6 |
0.0000 |
| 633 |
ERYTHEMA |
4 |
0.0000 |
| 634 |
ILLNESS |
2 |
0.0000 |
| 635 |
INFLAMMATION |
1 |
0.0000 |
| 636 |
HEADACHE |
12 |
0.0000 |
| 637 |
ECZEMA |
1 |
0.0000 |
| 638 |
DEPRESSED MOOD |
1 |
0.0000 |
| 639 |
OEDEMA |
1 |
0.0000 |
| 640 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 641 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 642 |
ARTHROPATHY |
1 |
0.0000 |
| 643 |
URTICARIA |
3 |
0.0000 |
| 644 |
COUGH |
5 |
0.0000 |
| 645 |
TOXICITY TO VARIOUS AGENTS |
3 |
0.0000 |
| 646 |
FLATULENCE |
1 |
0.0000 |
| 647 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 648 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 649 |
DYSPHONIA |
1 |
0.0000 |
| 650 |
IRRITABILITY |
1 |
0.0000 |
| 651 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 652 |
PRURITUS |
6 |
0.0000 |
| 653 |
FATIGUE |
12 |
0.0000 |
| 654 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 655 |
SWELLING FACE |
1 |
0.0000 |
| 656 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 657 |
PSORIASIS |
2 |
0.0000 |
| 658 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 659 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 660 |
DEHYDRATION |
2 |
0.0000 |
| 661 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 662 |
HYPOTENSION |
3 |
0.0000 |
| 663 |
ARTHRALGIA |
6 |
0.0000 |
| 664 |
WEIGHT DECREASED |
4 |
0.0000 |
| 665 |
SLEEP DISORDER |
1 |
0.0000 |
| 666 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 667 |
UNDERDOSE |
1 |
0.0000 |
| 668 |
PAIN IN EXTREMITY |
4 |
0.0000 |
| 669 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 670 |
ACNE |
1 |
0.0000 |
| 671 |
DIABETES MELLITUS |
1 |
0.0000 |
| 672 |
PARAESTHESIA |
2 |
0.0000 |
| 673 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 674 |
CARDIAC ARREST |
1 |
0.0000 |
| 675 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 676 |
TREMOR |
2 |
0.0000 |
| 677 |
MYALGIA |
2 |
0.0000 |
| 678 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 679 |
MALAISE |
5 |
0.0000 |
| 680 |
DRUG INEFFECTIVE |
15 |
0.0000 |
| 681 |
MUSCLE SPASMS |
2 |
0.0000 |
| 682 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 683 |
CHEST PAIN |
2 |
0.0000 |
| 684 |
ASTHENIA |
4 |
0.0000 |
| 685 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 686 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 687 |
HEART RATE INCREASED |
1 |
0.0000 |
| 688 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 689 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 690 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 691 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 692 |
CONSTIPATION |
2 |
0.0000 |
| 693 |
ASTHMA |
1 |
0.0000 |
| 694 |
PALPITATIONS |
1 |
0.0000 |
| 695 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 696 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 697 |
ANXIETY |
2 |
0.0000 |
| 698 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 699 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 700 |
FALL |
2 |
0.0000 |
| 701 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 702 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 703 |
DYSPNOEA |
3 |
0.0000 |
| 704 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 705 |
SOMNOLENCE |
1 |
0.0000 |
| 706 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 707 |
BACK PAIN |
1 |
0.0000 |
| 708 |
INSOMNIA |
1 |
0.0000 |
| 709 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 710 |
PAIN |
2 |
0.0000 |
| 711 |
DIZZINESS |
1 |
0.0000 |
| 712 |
DEATH |
1 |
0.0000 |